Black Diamond Therapeutics
BDTX
BDTX
112 hedge funds and large institutions have $705M invested in Black Diamond Therapeutics in 2021 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 36 increasing their positions, 31 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
112
Holders Change
+3
Holders Change %
+2.75%
% of All Funds
1.97%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
36
Reduced
31
Closed
20
Calls
$1.2M
Puts
$1.32M
Net Calls
-$123K
Net Calls Change
-$123K
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$23.6M |
| 2 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$20.4M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$10.4M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$6.69M |
| 5 |
Axa
Paris,
France
|
+$6.44M |
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$19.4M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$13.5M |
| 3 |
Jennison Associates
New York
|
-$11.7M |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
-$10.5M |
| 5 |
CC
Casdin Capital
New York
|
-$9.28M |
